CA74141E1043
© Newsfile
26.11.2025
PREV
LISTED
CSE
PreveCeutical Medical and BioGene Therapeutics Announce Closing of Plan of Arrangement
News Preview
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESVancouver, British Columbia--(Newsfile Corp. - November 26, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical") and BioGene Therapeutics Inc. ("BioGene"), are pleased to announce that, further...
Themefolio
Profiler
Peergroup
© Newsfile
24.11.2025
PREV
LISTED
CSE
CSE Bulletin: Notice of Distribution and Reclassification - PreveCeutical Medical Inc. (PREV)
News Preview
Toronto, Ontario--(Newsfile Corp. - Le 24 novembre/November 2025) - PreveCeutical Medical Inc. ("PreveCeutical") has announced the effective date of the reclassification as well as the previously announced plan of arrangement with BioGene Therapeutics Inc. ("BioGene") to occur on November 25, 2025. Pursuant to the Arrangeme...
Themefolio
Profiler
Peergroup
© Newsfile
20.11.2025
PREV
LISTED
CSE
PreveCeutical Provides Clarification of News Release Announcing Update on Plan of Arrangement with BioGene Therapeutics Inc.
News Preview
Vancouver, British Columbia--(Newsfile Corp. - November 20, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), announces that, further to its news release of earlier today, the Company wishes to clarify that shareholders of record of November 24, 2025 will be issued new common shar...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© Newsfile
20.11.2025
PREV
LISTED
CSE
PreveCeutical Provides Update on Plan of Arrangement with BioGene Therapeutics Inc.
News Preview
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESVancouver, British Columbia--(Newsfile Corp. - November 20, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), announces that, further to its News Releases of September 4, 2025, September 19, 202...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Newsfile
30.10.2025
PREV
LISTED
CSE
PreveCeutical Closes Second Tranche of Non-Brokered Private Placement
News Preview
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESVancouver, British Columbia--(Newsfile Corp. - October 30, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce that, further to its news releases of August 5, 2025, Sep...
Themefolio
Profiler
Peergroup
© Newsfile
20.10.2025
PREV
LISTED
CSE
PreveCeutical Provides Update on Plan of Arrangement with BioGene Therapeutics Inc.
News Preview
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESVancouver, British Columbia--(Newsfile Corp. - October 20, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce that, further to its News Releases of September 4, 2...
Themefolio
Profiler
Peergroup
© Newsfile
10.10.2025
PREV
LISTED
CSE
PreveCeutical Announces Results from Annual General and Special Meeting and Increase to Size of Non-Brokered Private Placement
News Preview
Vancouver, British Columbia--(Newsfile Corp. - October 10, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce that all resolutions presented at the Company's annual general and special meeting (the "Meeting") held on Friday, October 10, 2025, including the fo...
Themefolio
Profiler
Peergroup
© Newsfile
20.09.2025
PREV
LISTED
CSE
PreveCeutical Announces Mailing and Filing of Annual General and Special Meeting Materials in Connection with a Proposed Arrangement with BioGene Therapeutics
News Preview
Vancouver, British Columbia--(Newsfile Corp. - September 19, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), announces that further to its News Release of September 4, 2025, it has filed with the applicable Canadian securities regulatory authorities the management information ci...
Themefolio
Profiler
Peergroup
© Newsfile
05.09.2025
PREV
LISTED
CSE
PreveCeutical Closes Initial Tranche of Non-Brokered Private Placement
News Preview
Vancouver, British Columbia--(Newsfile Corp. - September 5, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce that, further to its news release dated August 5, 2025, it has closed an initial tranche (the "Initial Tranche") of its previously announced $1,000,...
Themefolio
Profiler
Peergroup
© Newsfile
04.09.2025
PREV
LISTED
CSE
PreveCeutical Announces Arrangement Agreement with BioGene Therapeutics
News Preview
Vancouver, British Columbia--(Newsfile Corp. - September 4, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) (the "Company" or "PreveCeutical") announces that it has entered into a definitive arrangement agreement (the "Arrangement Agreement") dated September 3, 2025 with its subsidiary, BioGene Therapeutics Inc. ("BioGe...
Themefolio
Profiler
Peergroup
© Newsfile
29.08.2025
PREV
LISTED
CSE
PreveCeutical Announces Rescheduled Date for Annual General and Special Meeting and Director Resignation
News Preview
Vancouver, British Columbia--(Newsfile Corp. - August 28, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) (the "Company" or "PreveCeutical") announces that, further to its News Release of June 25, 2025, July 8, 2025 and August 5, 2025, it has rescheduled its annual general and special meeting (the "Meeting") from Septem...
Themefolio
Profiler
Peergroup
© Newsfile
20.08.2025
PREV
LISTED
CSE
BioGene Therapeutics Inc. Appoints Dr. Francis Tavares, PhD., as Chief Technology Officer
News Preview
Vancouver, British Columbia--(Newsfile Corp. - August 20, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the "Company"), a health sciences company that develops innovative options for preventive and curative therapies utilizing organic and nature-identical products, is pleased to announce that its wholly...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Newsfile
19.08.2025
PREV
LISTED
CSE
BioGene Therapeutics Inc. Appoints Dr. Kamal Albarazanji as Senior Director of Metabolic Research
News Preview
Vancouver, British Columbia--(Newsfile Corp. - August 19, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the "Company"), a health sciences company that develops innovative options for preventive and curative therapies utilizing organic and nature-identical products, is pleased to announce that its wholly...
Themefolio
Profiler
Peergroup
© Newsfile
09.07.2025
PREV
LISTED
CSE
PreveCeutical Announces Rescheduled Date for Annual General and Special Meeting
News Preview
Vancouver, British Columbia--(Newsfile Corp. - July 9, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), announces that, further to its News Release of June 25, 2025, it has rescheduled its annual general and special meeting from August 15, 2025 to September 5, 2025 at which the s...
Themefolio
Profiler
Peergroup
© Newsfile
30.06.2025
PREV
LISTED
CSE
PreveCeutical Welcomes Dr. Francis Tavares, PhD. As Chief Technology Officer
News Preview
Vancouver, British Columbia--(Newsfile Corp. - June 30, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical" or the "Company"), a health sciences company that develops innovative options for preventive and curative therapies utilizing organic and nature-identical products, is pleased to have appointed...
Themefolio
Profiler
Peergroup
© Newsfile
25.06.2025
PREV
LISTED
CSE
PreveCeutical Announces Date for Annual General and Special Meeting
News Preview
Vancouver, British Columbia--(Newsfile Corp. - June 25, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce that it has scheduled its annual general and special meeting for August 15, 2025, at which the shareholders (the "PreveCeutical Shareholders") of the Co...
Themefolio
Profiler
Peergroup
© Newsfile
11.06.2025
PREV
LISTED
CSE
PreveCeutical Announces Non-Brokered Private Placement
News Preview
Vancouver, British Columbia--(Newsfile Corp. - June 11, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce a non-brokered private placement (the "Offering") of up to 15,000,000 units in the capital of the Company (the "Units")...
Themefolio
Profiler
Peergroup
© Newsfile
02.06.2025
PREV
LISTED
CSE
PreveCeutical Welcomes Dr. Deepak Sampath, PhD. as Corporate Advisor
News Preview
Vancouver, British Columbia--(Newsfile Corp. - June 2, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical" or the "Company"), a health sciences company that develops innovative options for preventive and curative therapies utilizing organic and nature-identical products, is pleased to have appointed D...
Themefolio
Profiler
Peergroup
© Newsfile
26.05.2025
PREV
LISTED
CSE
PreveCeutical Welcomes Stephen Glover as Corporate Advisor
News Preview
Vancouver, British Columbia--(Newsfile Corp. - May 26, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the "Company"), a health sciences company that develops innovative options for preventive and curative therapies utilizing organic and nature-identical products, is pleased to announce that Steve Glover...
Themefolio
Profiler
Peergroup
© Newsfile
22.05.2025
PREV
LISTED
CSE
PreveCeutical Closes Final Tranche of Up-Sized Non-Brokered Private Placement
News Preview
Vancouver, British Columbia--(Newsfile Corp. - May 22, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce that, following its news releases dated April 2, 2025, April 14, 2025, and April 28, 2025, it has successfully closed the final tranche ("Final Tranche")...
Themefolio
Profiler
Peergroup
© Newsfile
14.05.2025
PREV
LISTED
CSE
PreveCeutical Medical Inc. Announces Launch of New Website for BioGene Therapeutics Inc., Expanding Its Digital Presence to Enhance Accessibility and Awareness of Innovative Therapies
News Preview
Vancouver, British Columbia--(Newsfile Corp. - May 14, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical"), a health sciences company that develops innovative options for preventive and curative therapies utilizing organic and nature-identical products, is thrilled to announce that BioGene Therapeutics Inc. ("...
Themefolio
Profiler
Peergroup
© Newsfile
28.04.2025
PREV
LISTED
CSE
PreveCeutical Closes Initial Tranche of Up-Sized Non-Brokered Private Placement
News Preview
Vancouver, British Columbia--(Newsfile Corp. - April 28, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce that, further to its news releases dated April 2, 2025 and April 14, 2025, it has closed an initial tranche (the "Initial Tranche") of its previously a...
Themefolio
Profiler
Peergroup
© Newsfile
15.04.2025
PREV
LISTED
CSE
PreveCeutical Announces Up-Sized Non-Brokered Private Placement
News Preview
Vancouver, British Columbia--(Newsfile Corp. - April 14, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical") announces that, further to its news release dated April 2, 2025, that the Company will be increasing the size of its previously announced non- brokered private placement (the "Offering"...
Themefolio
Profiler
Peergroup
© Newsfile
03.04.2025
PREV
LISTED
CSE
PreveCeutical Announces Update to Non-Brokered Private Placement
News Preview
Vancouver, British Columbia--(Newsfile Corp. - April 2, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce a non-brokered private placement (the "Offering") of up to 16,666,667 units in the capital of the Company (the "Units") at a price of $0.03 per Unit for gross pr...
Themefolio
Profiler
Peergroup
© Newsfile
10.03.2025
PREV
LISTED
CSE
PreveCeutical Announces Update to Private Placement
News Preview
Vancouver, British Columbia--(Newsfile Corp. - March 10, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), announces that further to its news release dated January 24, 2025, the Company has received an extension from The CSE (the "CSE") to close its non-brokered private placement of up to 1...
Themefolio
Profiler
Peergroup
© Newsfile
06.02.2025
PREV
LISTED
CSE
PreveCeutical to Develop Sol-Gel N2B Platform for Parkinson's Disease
News Preview
Vancouver, British Columbia--(Newsfile Corp. - February 6, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), announces a program aiming to deliver Dopamine and/or its precursor L-Dopa directly to the brain using their Nose to Brain (N2B) Sol-Gel platform delivery technology.PreveCeutical's...
Themefolio
Profiler
Peergroup
© Newsfile
04.02.2025
PREV
LISTED
CSE
Appointment of Dr. Bryan Jones as an Advisor to Lead Sol-Gel Special Projects
News Preview
Vancouver, British Columbia--(Newsfile Corp. - February 4, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H), (the "Company" or "PreveCeutical") a health sciences company that develops innovative options for preventive and curative therapies utilizing organic and nature identical products is pleased to announce that is has ap...
Themefolio
Profiler
Peergroup
© Newsfile
24.01.2025
PREV
LISTED
CSE
PreveCeutical Announces Non-Brokered Private Placement
News Preview
Vancouver, British Columbia--(Newsfile Corp. - January 24, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce a non-brokered private placement (the "Offering") of up to 10,000,000 units in the capital of the Company (the "Units") at a price of $0.03 per Unit for gross...
Themefolio
Profiler
Peergroup
© Newsfile
07.01.2025
PREV
LISTED
CSE
BioGene Therapeutics to Participate in the 43rd JP Morgan Healthcare Conference
News Preview
Vancouver, British Columbia--(Newsfile Corp. - January 7, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical" or the "Company"), a health sciences company that develops innovative options for preventive and curative therapies utilizing organic and nature-identical products, is pleased to announce that its wholl...
Themefolio
Profiler
Peergroup
© Newsfile
18.12.2024
PREV
LISTED
CSE
PreveCeutical Announces Change of Auditors
News Preview
Vancouver, British Columbia--(Newsfile Corp. - December 18, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), announces that the Company has changed its auditor from Smythe LLP, Certified Public Accountants ("Former Auditor") to Davidson & Company LLP, Certified Professional Accounts (...
Themefolio
Profiler
Peergroup
© Newsfile
09.12.2024
PREV
LISTED
CSE
BioGene Therapeutics Appoints Patroski J. Lawson to Board of Directors
News Preview
Vancouver, British Columbia--(Newsfile Corp. - December 9, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the "Company"), a health sciences company that develops innovative options for preventive and curative therapies utilizing organic and nature-identical products, is pleased to announce that its wholl...
Themefolio
Profiler
Peergroup
© Newsfile
05.12.2024
PREV
LISTED
CSE
BioGene Therapeutics Welcomes Ex Pfizer and Moderna Senior Leadership Dr. Barry Ticho
News Preview
Vancouver, British Columbia--(Newsfile Corp. - December 5, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical" or the "Company"), a health sciences company that develops innovative options for preventive and curative therapies utilizing organic and nature-identical products, is pleased to announce that its whol...
Themefolio
Profiler
Peergroup
© Newsfile
04.12.2024
PREV
LISTED
CSE
BioGene Therapeutics Announces Appointment of Dr. Brian Gallagher, Jr. to Corporate Advisory Board
News Preview
Vancouver, British Columbia--(Newsfile Corp. - December 4, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the "Company"), a health sciences company that develops innovative options for preventive and curative therapies utilizing organic and nature-identical products, is pleased to announce that its wholl...
Themefolio
Profiler
Peergroup
© Newsfile
02.12.2024
PREV
LISTED
CSE
BioGene Therapeutics Welcomes Stephen Glover to Its Board of Directors
News Preview
Vancouver, British Columbia--(Newsfile Corp. - December 2, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the "Company"), a health sciences company that develops innovative options for preventive and curative therapies utilizing organic and nature-identical products, is pleased to announce that its wholl...
Themefolio
Profiler
Peergroup
© Newsfile
25.11.2024
PREV
LISTED
CSE
BioGene Therapeutics Welcomes Dr. Deepak Sampath, PhD. to Its Board of Directors
News Preview
Vancouver, British Columbia--(Newsfile Corp. - November 25, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the "Company"), a health sciences company that develops innovative options for preventive and curative therapies utilizing organic and nature-identical products, is pleased to announce that its whol...
Themefolio
Profiler
Peergroup
© Newsfile
21.11.2024
PREV
LISTED
CSE
BioGene Therapeutics Welcomes Professor Mirela Delibegovic, FRSE to Its Scientific Advisory Board
News Preview
Vancouver, British Columbia--(Newsfile Corp. - November 21, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the "Company"), a health sciences company that develops innovative options for preventive and curative therapies utilizing organic and nature-identical products, is pleased to announce that its whol...
Themefolio
Profiler
Peergroup
© Newsfile
18.11.2024
PREV
LISTED
CSE
PreveCeutical's Subsidary, Biogene Therapeutics Announces Strategic Appointments: Dr. Linnea Olofsson as Chief Scientific Officer and Dr. Harry Parekh as Chief Research Officer
News Preview
Vancouver, British Columbia--(Newsfile Corp. - November 18, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the "Company"), a health sciences company that develops innovative options for preventive and curative therapies utilizing organic and nature-identical products, is pleased to announce that its whol...
Themefolio
Profiler
Peergroup
© Newsfile
15.11.2024
PREV
LISTED
CSE
PreveCeutical Announces Closing of BioGene Therapeutics Transaction
News Preview
Vancouver, British Columbia--(Newsfile Corp. - November 15, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical" or the "Company"), a health sciences company that develops innovative options for preventive and curative therapies utilizing organic and nature-identical products, is pleased to announce that, furthe...
Themefolio
Profiler
Peergroup
© Newsfile
13.11.2024
PREV
LISTED
CSE
PreveCeutical's Subsidiary, BioGene Therapeutics, Appoints President
News Preview
Vancouver, British Columbia--(Newsfile Corp. - November 13, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the "Company"), a health sciences company that develops innovative options for preventive and curative therapies utilizing organic and nature-identical products, is pleased to announce that its who...
Themefolio
Profiler
Peergroup
© Newsfile
30.10.2024
PREV
LISTED
CSE
PreveCeutical Launches Strategic Partnership with BioGene Therapeutics
News Preview
Vancouver, British Columbia--(Newsfile Corp. - October 30, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the "Company"), a health sciences company that develops innovative options for preventive and curative therapies utilizing organic and nature-identical products, is pleased to announce that it has si...
Themefolio
Profiler
Peergroup
© Newsfile
18.10.2024
PREV
LISTED
CSE
PreveCeutical Engages Phoenix Corporate Finance Inc. to Provide Advisory Services
News Preview
Vancouver, British Columbia--(Newsfile Corp. - October 18, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical" or the "Company"), a health sciences company that develops innovative options for preventive and curative therapies utilizing organic and nature-identical products, is pleased to announce that it has e...
Themefolio
Profiler
Peergroup
© Newsfile
03.09.2024
PREV
LISTED
CSE
PreveCeutical Engages Outside The Box Capital Inc. to Provide Marketing Services
News Preview
Vancouver, British Columbia--(Newsfile Corp. - September 3, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), announces that it has entered into a Marketing Service Agreement dated effective September 1, 2024 (the "Agreement") with Outside the Box Capital Ltd. ("OTB"), whereby OTB will prov...
Themefolio
Profiler
Peergroup
© Newsfile
09.07.2024
PREV
LISTED
CSE
Preveceutical Announces Revocation of Management Cease Trade Order
News Preview
Vancouver, British Columbia--(Newsfile Corp. - July 9, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical") is pleased to announce that, further to the Company's news release dated June 28, 2024, the Company has completed the filings of its interim financial statements, accompanying management'...
Themefolio
Profiler
Peergroup
© Newsfile
29.06.2024
PREV
LISTED
CSE
PreveCeutical Provides Update on Management Cease Trade Order
News Preview
Vancouver, British Columbia--(Newsfile Corp. - June 28, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical") is pleased to announce that today it has filed its audited annual financial statements and accompanying management's discussion and analysis, with related CEO and CFO certificates, for t...
Themefolio
Profiler
Peergroup
© Newsfile
17.06.2024
PREV
LISTED
CSE
PreveCeutical Enters into Loan Agreements
News Preview
Vancouver, British Columbia--(Newsfile Corp. - June 17, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical") announces that it has entered into a series of unsecured, non-convertible and interest-free loan agreements with, the Company's Chief Executive Officer, interim Chief Financial Officer a...
Themefolio
Profiler
Peergroup
© Newsfile
14.06.2024
PREV
LISTED
CSE
PreveCeutical Provides Update on Management Cease Trade Order
News Preview
Vancouver, British Columbia--(Newsfile Corp. - June 14, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical") is providing an update with respect to the Management Cease Trade Order ("MCTO") issued by the British Columbia Securities Commission (the "BCSC") under National Policy 12-203 - Manageme...
Themefolio
Profiler
Peergroup
© Newsfile
30.05.2024
PREV
LISTED
CSE
Preveceutical Provides Update on Management Cease Trade Order
News Preview
Vancouver, British Columbia--(Newsfile Corp. - May 30, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical") is providing an update with respect to the Management Cease Trade Order ("MCTO") issued by the British Columbia Securities Commission (the "BCSC") under National Policy 12-203 - Man...
Themefolio
Profiler
Peergroup
© Newsfile
30.05.2024
PREV
LISTED
CSE
Preveceutical Announces First Tranche Closing of Private Placement
News Preview
Vancouver, British Columbia--(Newsfile Corp. - May 29, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical") is pleased to announce that further to its news release dated May 16, 2024, the Company has closed the first tranche of its non-brokered private placement (the "Private Placement") for gr...
Themefolio
Profiler
Peergroup
© Newsfile
17.05.2024
PREV
LISTED
CSE
PreveCeutical Provides Update on Management Cease Trade Order
News Preview
Vancouver, British Columbia--(Newsfile Corp. - May 16, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical") is providing an update with respect to the Management Cease Trade Order ("MCTO") issued by the British Columbia Securities Commission (the "BCSC") under National Policy 12-203 - Managemen...
Themefolio
Profiler
Peergroup
© Newsfile
03.05.2024
PREV
LISTED
CSE
PreveCeutical Announces Management Cease Trade Order
News Preview
Vancouver, British Columbia--(Newsfile Corp. - May 2, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical") announces that the Company has missed the filing deadline of April 29, 2024 to file the Company's audited annual financial statements and accompanying management's discussion and...
Themefolio
Profiler
Peergroup
© Newsfile
28.06.2023
PREV
LISTED
CSE
PreveCeutical Files Two Family Patents of Sol-Gel Cannabinoid Formulation and Antiviral Use & Cyclic Peptides and Uses Thereof
News Preview
Vancouver, British Columbia--(Newsfile Corp. - June 28, 2023) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce that PreveCeutical is furthering the progress of two of its patent families.The patent family based on PCT/AU2021/051383 (P114915, Sol-gel cannabinoid f...
Themefolio
Profiler
Peergroup
© Newsfile
30.05.2023
PREV
LISTED
CSE
PreveCeutical Medical - Sol-Gel and Uses thereof Patent Update
News Preview
Vancouver, British Columbia--(Newsfile Corp. - May 30, 2023) - PreveCeutical Medical Inc. (the "Company" or "PreveCeutical") (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H), is pleased to announce that PreveCeutical is furthering the progress of its patent family directed to Sol-Gel (International Patent Application No. PCT/AU2021/051383, Sol-Gel Cannabinoid...
Themefolio
Profiler
Peergroup
© Newsfile
24.04.2023
PREV
LISTED
CSE
PreveCeutical Medical Launches Clinical Artificial Intelligence Division
News Preview
Vancouver, British Columbia--(Newsfile Corp. - April 24, 2023) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce that on April 21, 2023, PreveCeutical created a new division to develop and train an Artificial Intelligence (AI) tool that will be capable of learning R&D,...
Themefolio
Profiler
Peergroup
© Newsfile
20.04.2023
PREV
LISTED
CSE
PreveCeutical Medical Announces Live Interactive Q&A Video Conference
News Preview
Vancouver, British Columbia--(Newsfile Corp. - April 20, 2023) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce that Stephen Van Deventer will be participating in a live interactive video conference Q&A forum on April 25, 2023.All participants are encouraged...
Themefolio
Profiler
Peergroup
© Newsfile
04.04.2023
PREV
LISTED
CSE
PreveCeutical Medical Announces Frontiers Media SA Publication Featuring Data from its Analgesic Program for the Treatment of Peptide-based Therapeutics for Moderate to Severe Pain
News Preview
Synthesized Kappa Opioid Receptors (KOP) Appear to be Devoid of Many Problematic Mu Receptor Side-effects Such as Tolerance, Addiction, Sedation, and Euphoria/Dysphoria,KOP Peptides Showed Significant Opioid-like Antinociception Comparable to Morphine and U50844HPreveCeutical's Pain Management Peptides Program Published in the Swiss Medical Journal...
Themefolio
Profiler
Peergroup
© Newsfile
20.03.2023
PREV
LISTED
CSE
PreveCeutical Initiates Non-Analgesic (Painkiller) Program, Clinical Development Program & Disclosure Committee
News Preview
Vancouver, British Columbia--(Newsfile Corp. - March 20, 2023) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce that PreveCeutical commenced clinical work with our selected clinical research organization (CRO) as announced on February 7, 2023, to complete the fol...
Themefolio
Profiler
Peergroup
© Newsfile
06.03.2023
PREV
LISTED
CSE
PreveCeutical - International Filing of Thermoresponsive Sol-Gels Containing Cannabinoids & Uses Thereof
News Preview
Vancouver, British Columbia--(Newsfile Corp. - March 6, 2023) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce that PreveCeutical is furthering the progress of its Sol-Gel Cannabinoid Therapies patent family based on International Patent Application PCT/IB2021/02...
Themefolio
Profiler
Peergroup
© Newsfile
21.02.2023
PREV
LISTED
CSE
Appointment of C. Evan Ballantyne to PreveCeutical's Board of Directors
News Preview
Vancouver, British Columbia--(Newsfile Corp. - February 21, 2023) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical") announces the appointment of Mr. Evan Ballantyne to the Company's board of directors (the "Board") effective February 17, 2023.Mr. Ballantyne has extensive executive l...
Themefolio
Profiler
Peergroup
© Newsfile
07.02.2023
PREV
LISTED
CSE
PreveCeutical Awards ICON Analgesic Program (Painkiller) Clinical Development
News Preview
Vancouver, British Columbia--(Newsfile Corp. - February 7, 2023) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce that on February 1, 2023, PreveCeutical has appointed ICON as the clinical research organization (CRO) to complete the following.Conduct a comprehens...
Themefolio
Profiler
Peergroup
© Newsfile
25.01.2023
PREV
LISTED
CSE
PreveCeutical - Australian Patent Granted for Disulfide Bond Containing Compounds
News Preview
Vancouver, British Columbia--(Newsfile Corp. - January 25, 2023) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce the grant of Australian patent no. 2018305726, titled "Disulfide bond containing compounds and uses thereof," on January 5, 2023. The patent is owned...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
